Envoy Medical Inc. (COCH)
Envoy Medical Statistics
Share Statistics
Envoy Medical has 21.33M shares outstanding. The number of shares has increased by 8.64% in one year.
Shares Outstanding | 21.33M |
Shares Change (YoY) | 8.64% |
Shares Change (QoQ) | 5.18% |
Owned by Institutions (%) | n/a |
Shares Floating | 10.09M |
Failed to Deliver (FTD) Shares | 5.23K |
FTD / Avg. Volume | 27.09% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.29 and the forward PE ratio is -2.46. Envoy Medical's PEG ratio is 0.03.
PE Ratio | -1.29 |
Forward PE | -2.46 |
PS Ratio | 119.42 |
Forward PS | 1.3 |
PB Ratio | -1.43 |
P/FCF Ratio | -1.42 |
PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Envoy Medical.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of -0.05.
Current Ratio | 1.24 |
Quick Ratio | 1.02 |
Debt / Equity | -0.05 |
Debt / EBITDA | -0.05 |
Debt / FCF | -0.05 |
Interest Coverage | -23.6 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $5.36K |
Profits Per Employee | $-495.12K |
Employee Count | 42 |
Asset Turnover | 0.02 |
Inventory Turnover | 0.43 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -71.15% in the last 52 weeks. The beta is 2.33, so Envoy Medical's price volatility has been higher than the market average.
Beta | 2.33 |
52-Week Price Change | -71.15% |
50-Day Moving Average | 1.39 |
200-Day Moving Average | 2.09 |
Relative Strength Index (RSI) | 58.42 |
Average Volume (20 Days) | 19.3K |
Income Statement
In the last 12 months, Envoy Medical had revenue of 225K and earned -20.8M in profits. Earnings per share was -1.49.
Revenue | 225K |
Gross Profit | -517K |
Operating Income | -19.26M |
Net Income | -20.8M |
EBITDA | -19.81M |
EBIT | -19.98M |
Earnings Per Share (EPS) | -1.49 |
Balance Sheet
The company has 5.48M in cash and 945K in debt, giving a net cash position of 4.54M.
Cash & Cash Equivalents | 5.48M |
Total Debt | 945K |
Net Cash | 4.54M |
Retained Earnings | -284.73M |
Total Assets | 11.54M |
Working Capital | 1.85M |
Cash Flow
In the last 12 months, operating cash flow was -17.95M and capital expenditures -980K, giving a free cash flow of -18.93M.
Operating Cash Flow | -17.95M |
Capital Expenditures | -980K |
Free Cash Flow | -18.93M |
FCF Per Share | -1.01 |
Margins
Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.
Gross Margin | -229.78% |
Operating Margin | -8558.22% |
Pretax Margin | -9242.22% |
Profit Margin | -9242.22% |
EBITDA Margin | -8802.67% |
EBIT Margin | -8558.22% |
FCF Margin | -8412.89% |
Dividends & Yields
COCH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for COCH is $9.12, which is 524.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $9.12 |
Price Target Difference | 524.7% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | -39.46 |
Piotroski F-Score | 4 |